Meningiomas are the most common intracranial tumor, making up more than a third of all
primary central nervous system (CNS) tumors. They are mostly benign tumors that can be …

Purpose To systematically review and evaluate the methodological quality of studies using
radiomics for diagnostic and predictive purposes in patients with intracranial meningioma …

Recurrence of meningiomas is unpredictable by current invasive methods based on
surgically removed specimens. Identification of patients likely to recur using noninvasive …

Background There is a critical need for objective and reliable biomarkers of outcome in
meningiomas beyond WHO classification. Loss of H3K27me3 has been reported as a …

Purpose To provide practice guideline/procedure standards for diagnostics and therapy
(theranostics) of meningiomas using radiolabeled somatostatin receptor (SSTR) ligands …

Background Brain invasion by meningioma is a stand-alone criterion for tumor atypia in the
2016 World Health Organization classification, but no imaging parameter has yet been …

Somatostatin receptor (SSTR) 2, widely expressed in meningioma, is a G-protein-coupled
receptor and can be activated by somatostatin or its synthetic analogs. SSTR2 is therefore …

Background Brain invasion in meningioma has independent associations with increased
risks of tumor progression, lesion recurrence, and poor prognosis. Therefore, this study …

Purpose This study aimed to investigate the clinical usefulness of the enhanced-T1WI-based
deep learning radiomics model (DLRM) in differentiating low-and high-grade meningiomas …

The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT)
challenge aims to advance automated segmentation algorithms using the largest known …